Question

I am a breastfeeding mother and i want to know if it is safe to use Carteolol Hydrochloride (Ophtalmic Use)? Is Carteolol Hydrochloride (Ophtalmic Use) safe for nursing mother and child? Does Carteolol Hydrochloride (Ophtalmic Use) extracts into breast milk? Does Carteolol Hydrochloride (Ophtalmic Use) has any long term or short term side effects on infants? Can Carteolol Hydrochloride (Ophtalmic Use) influence milk supply or can Carteolol Hydrochloride (Ophtalmic Use) decrease milk supply in lactating mothers?

Carteolol Hydrochloride (Ophtalmic Use) lactation summary

Carteolol Hydrochloride (Ophtalmic Use) is safe in breastfeeding
  • DrLact safety Score for Carteolol Hydrochloride (Ophtalmic Use) is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of Carteolol Hydrochloride (Ophtalmic Use) is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that Carteolol Hydrochloride (Ophtalmic Use) does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of Carteolol Hydrochloride (Ophtalmic Use) safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Carteolol Hydrochloride (Ophtalmic Use) usage in lactation

At date of last update were not found published data on its excretion into breast milk. Because of a small dose and low absorption to the plasma in a majority of ophthalmic preparations that are topically used, a significant excretion into the milk is unlikely, thus it is considered of very low risk while breastfeeding in this cases. It would be advisable to press on the lacrimal area or tightly close the eyes for a couple of minutes (nasolacrimal occlusion) to minimize the systemic absorption. The risk can be further minimized by the use of beta-blocking agents with a higher protein-binding capacity.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.